The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.

On March 6, President Donald Trump instituted a 25 percent ad valorem rate of duty on goods imported from Canada under the International Emergency Economic Powers Act.[1] The tariffs will not be implemented on goods that comply with the United States-MexicoCanada Agreement until April 2.[2] In turn, Canada has announced a $155 billion tariff package on the US.[3]

Download the full Law360 article, "Mitigating Tariff Risks For Healthcare In US And Canada."



Contacts

Jeff Wurzburg
Jeff Wurzburg
Partner
Email
jeff.wurzburg@nortonrosefulbright.com
T: +1 210 270 9338
Vanessa Grant
Vanessa Grant
Senior Partner
Email
vanessa.grant@nortonrosefulbright.com
T: +1 416 216 4056

Practice areas:

Industry:

Recent publications

Publication

UK Pensions Briefing | Pension Schemes Bill – highlights for DB arrangements

The Pension Schemes Bill offers the prospect of access to surplus, definitive rules for superfunds, a reduced PPF levy and easier recovery of overpayments. Change is underway.

United Kingdom | June 23, 2025

Financial institutions

Publication

Charlotte Hillyard on AI Integration, Law Firm Tech Procurement and Legal Tech Evaluation 

Charlotte Hillyard, Senior Innovation Lawyer in the Innovation Design and Technology team and one of Norton Rose Fulbright's Generative AI leads, will be sharing her insight at several prominent legal technology events in the coming week. 

Global | June 20, 2025

London skyscrapers

Publication

Essential Corporate News – Week ending 20 June 2025

On 17 June 2025, Companies House published its corporate business plan for April 2025 to March 2026. Publication of Companies House strategy for 2025 to 2030 is expected later in 2025.

United Kingdom | June 20, 2025

Corporate, M&A and securities
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Register now